Genomic Answers for Children’s Health Act of 2026
Congress Proposes Requiring Medicaid to Cover Advanced Genetic Testing for Children with Rare Diseases
Legislative Progress
Key Points
- This bill, introduced in Congress, would require Medicaid to pay for advanced genetic testing, known as whole genome and whole exome sequencing, for children. It is designed for kids who have suspected rare diseases, genetic disorders, or unexplained health issues like developmental delays or intellectual disabilities.
- Doctors would be allowed to order these tests as a first-tier option to find answers for a child's condition. The policy also covers testing for a child's parents or siblings if that information is necessary to help diagnose or treat the child's specific medical needs.
- To ensure these tests are accessible, the bill requires Medicaid to pay for them separately rather than bundling them into a general hospital bill. This prevents the high cost of the tests from being a financial barrier for hospitals and clinics that serve low-income families.
- The Department of Health and Human Services would be required to work with doctors, hospitals, and patient groups to spread awareness about this coverage. They must also track how many children receive these tests and whether the testing leads to better health outcomes or changes in medical care.
- If passed, these new rules would take effect on January 1, 2027. The government would also be required to study remaining challenges, such as insurance paperwork delays or a shortage of genetic counselors, to make sure families can actually get the help they need.
Impact Analysis
Personal Impact
How this policy affects specific groups of people
Milestones
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
5 articlesUS Lawmakers Introduce Bill to Cover Genomic Sequencing in Sick Children
A bipartisan coalition introduced the Genomic Answers for Children’s Health Act to mandate Medicaid coverage for whole genome and whole exome sequencing. The bill aims to end the 'diagnostic odyssey' for children with rare diseases by clarifying that these tests are covered under EPSDT benefits.
Gus Bilirakis Introduces Bill Expanding Children's Genomic Sequencing Access Under Medicaid
Rep. Gus Bilirakis (R-FL) introduced the Genomic Answers for Children’s Health Act to clarify that genomic sequencing is a qualified part of Medicaid’s Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) system, helping families avoid years of costly and uncertain diagnostic testing.
Baylor Genetics Supports Bipartisan House Bill to Broaden Medicaid Access to Genomic Sequencing for Children who Meet Medical Criteria
Baylor Genetics and a coalition of 28 organizations announced support for the Genomic Answers for Children's Health Act. The legislation requires Medicaid to provide a separate payment for inpatient sequencing, preventing high costs from becoming a financial barrier to access for families.
Source Information
Document Type
Congressional Bill
Official Title
Genomic Answers for Children’s Health Act of 2026
Data Sources
Sponsor
Cosponsors
(15)Analysis generated by AI. Always verify with official sources.